All Issue

2021 Vol.2, Issue 4 Preview Page

Case report

31 December 2021. pp. 149-151
Sorry, not available.
Click the PDF button.
Huggins C et al., Studies on prostate cancer: 1. The effects of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate, Cancer Res, 1941
Denmeade SR et al., Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen ablation in men with castration resistant prostate cancer, Prostate, 2010 10.1002/pros.2119620607766PMC4124628
Xiong X et al., Efficacy and safety of bipolar androgen therapy in mCRPC after progression on abiraterone or enzalutamide: A systemic review, Urol Oncol, 2021
Bipolar androgen-based therapy for prostate cancer (BAT). identifier: NCT 01750398, 2012
Teply BA et al., Bipolar androgen therapy in men with metastatic castration resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study, Lancet Oncol, 2018 10.1016/S1470-2045(17)30906-3
Sena LA et al., Bipolar androgen therapy sensitizes castration resistant prostate cancer to subsequent androgen receptor ablative therapy, Eur J Cancer, 2021 10.1016/j.ejca.2020.11.04333383350
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 2
  • No :4
  • Pages :149-151